for increasing donor availability, identifying suitable organ recipients, and documenting transplant procedures.
To help efficiently manage the data that must be processed in carrying out recipient selection and organ and tissue allocation, Javier Vázquez-Salceda and his colleagues have proposed and formalized Carrel, an agent-based architecture. 1 Carrel helps organizations adhere to legislation, follow approved protocols, and prepare delivery plans. We propose changing the organ selection process to allow for more deliberation regarding an organ's viability; Carrel+, our extension of Carrel, can accommodate such changes.
Currently, deciding whether to offer an available organ is based exclusively on the assessment of experts at the donor site. However, Carrel+ can coordinate joint deliberation between donor and recipient agents (representing professionals responsible for the donor and recipients, respectively) in an argument-based dialogue and can subsequently evaluate the exchanged arguments. So, an organ that an expert (at the donor site) might ordinarily discard could still be transplanted if a recipient agent can successfully argue that the organ is viable for that agent's recipient.
Carrel
Since 1980, the number of transplant requests has been constantly increasing, so human transplant coordinators now face significant problems in managing the number of requests and assigning and distributing tissues and organs. Carrel aims to automate many of the tasks that humans currently carry out.
To perform these tasks, Carrel must manage and process vast amounts of data and adhere to complex and sometimes conflicting sets of national and international regulations and protocols governing the exchange of organs and tissues. It encodes sets of legislation and protocols from two organ transplantation organizations that exemplify best practices: Catalonia's OCATT (Organització Catalana de Trasplantaments, www10.gencat.net/catsalut/ocatt/ en/htm/index.htm) and Spain's ONT (Organización Nacional de Transplantes, www.ont.es).
Spain has improved its organ transplant process by creating a model with two organizational levels:
• At the intrahospital level, a hospital's transplant coordinator coordinates everyone involved in donor procurement, organ allocation, and transplantation. Figure 1 illustrates Carrel managing the interhospital level and shows the entities with which it interacts. OCATT and ONT denote the organ transplantation organizations that own the agent platform and act as observers (they have special access to the agent platform). Each transplant coordination unit (UCT) represents a hospital associated with Carrel. 2 The UCTs manage the intrahospital level; each UCT aims to successfully coordinate organ and tissue procurement, extraction, and implantation, and in turn each is modeled as an agency.
Carrel must
• ensure that all the agents entered into the system follow behavioral norms, • remain informed of all the recipients registered on the waiting lists, • check that all hospitals fulfill the requirements needed to interact with Carrel, • coordinate the organ or tissue delivery from one facility to another, and • register all incidents relating to a particular organ or tissue.
A hospital must join the Carrel system to use its services. In doing so, the hospital undertakes an obligation to respect the norms ruling Carrel interactions. For example,
• Carrel must process all organ offers and tissue requests, • hospitals must accept the outcomes of the assignation process, and • hospitals must update Carrel with any relevant event related to organs and tissues received through Carrel.
Carrel is a dialogical system in which all interactions are compositions of message exchanges, or illocutions, structured through agent group meetings called scenes or rooms. Each agent can have one or more roles, which define the rooms the agent can enter and the protocols it should follow. So, extending Carrel involves defining new roles or illocutions, where the former might require defining new rooms.
For example, the task of offering an organ for transplantation and searching for a recipient is fulfilled by having UCT agents take on the hospital finder agent role. Similarly, when Carrel contacts a UCT to say there is an available organ suitable for a recipient on that UCT's waiting list, the UCT agent takes on the hospital contact agent role.
(Other researchers have proposed similar multiagent approaches for providing support to medical practitioners for data management and decision making in the transplant domain. 3, 4 However, as in Carrel, these approaches assume the current human-organ selection process, which doesn't allow for deliberation regarding organ viability.)
The current organ selection process
In Spain, the human-organ selection process begins when a transplant coordinator, represented by a UCT's donor agent (DA), detects a potential donor. ("Agent" can refer to either a human or an automated software agent.) After analyzing the relevant donor's characteristics, the DA informs OCATT (assuming the DA is in Catalonia) of the organs it considers viable for transplantation. Any organ deemed nonviable is simply discarded (in other words, surgeons won't extract it from the donor).
If the DA finds a recipient, allocation starts and OCATT offers the organ to a Catalan recipient agent, RA. This agent might or might not accept the organ. (It's worth mentioning that, at this stage, the offered organ hasn't yet been extracted.) If the RA refuses the organ, OCATT will offer the organ to other RAs until either one accepts it or all have refused it. The RA that accepts the organ can discard it during or after extraction, in which case it's likely that the organ won't be transplanted. If no RA on Catalonia's waiting list accepts the organ, OCATT will offer it to ONT, and a similar process takes place, this time embracing all of Spain. If all RAs refuse the organ, ONT will offer it to transplant organizations in Europe. If every organization fails to allocate the organ, the organ will be discarded.
In 2005, OCATT reported that Catalonia, a leader in organ transplantations, discarded approximately 20 percent of livers and kidneys, 60 percent of hearts, 85 percent of lungs, and 95 percent of pancreases. 5 It has been acknowledged that these discard rates can be reduced by accounting for two factors currently not considered in the current organ selection process. 6 First, doctors often disagree as to whether an organ is viable, and different hospitals and regions have different policies. Second, organs are rarely viable or nonviable per se; rather, assessment of viability should depend on both the donor and potential recipient characteristics as well as on the courses of action to be undertaken during transplantation
We propose an argument based framework for deliberation that accounts for these factors.
An argument-based framework for deliberation
Human-organ selection illustrates the ubiquity of disagreement and conflict of opinion in the medical domain. What might be sufficient reason for discarding an organ for some qualified professionals might not be for others.
Consider a donor with a smoking history of more than 20 to 30 packs of cigarettes per year and no history of chronic obstructive pulmonary disease (COPD). Some would cite the donor's smoking history as sufficient reason for deeming the lung nonviable, but others would disagree given there's no history of COPD. 5 Similarly, some would discard the kidney of a donor who died from streptococcus viridans endocarditis. Others would reason that by administrating penicillin to the recipient, they could safely transplant the kidney. 7 So, although DA i (DA of UCT i ) might argue that an organ is nonviable, RA j (RA of UCT j ) might provide a stronger argument for considering the organ as viable. On the other hand, DA i might argue that an organ is viable, and this argument might be stronger than an RA's argument for nonviability, thus making the RA reconsider. By enabling supervised and validated argumentation over a human organ's viability, we can safely reduce the number of discarded organs. In modifying Carrel to support a new selection process, we used the argument-based model ProCLAIM, 8 which defines a setting for proponent agents (such as DAs and RAs) to argue their intended decisions' validity. Pro-CLAIM features a mediator agent (MA) that directs these proponent agents in their deliberation and subsequently evaluates the submitted arguments to conclude whether a proposed decision is valid. So, the main extension in Carrel+ is the MA role for managing the DAs and RAs deliberating over an available organ's viability.
The deliberation takes place in two new rooms: the donor evaluation room and recipient evaluation room. For simplicity, we refer to these as just the evaluation room. Another extension is the transplant organization agent (TOA) and transplant organization room, which distribute organ offers to the appropriate recipient agents (see figure 2a) .
The DA and RA extend the roles of a UCT's hospital finder agent and hospital contact agent, respectively, to facilitate the submission of arguments relevant to assessing an offered organ's viability in the evaluation room. In the new selection process, having identified a potential donor, DA i will enter the transplant organization room and communicate basic organ data (for example, organ type) and donor data (such as the donor's clinical history) to the TOA representing OCATT or ONT. The TOA may delegate the offer to another transplant organization or pass the offer to the evaluation room, in which case the TOA contacts each RA j identified as a potential recipient on the basis of basic organ and donor data. The MA in the evaluation room then mediates the exchange of RA j and DA i arguments for and against viability, possibly submitting additional arguments (see figure 2b) . Finally, the MA evaluates the submitted arguments to decide whether the offered organ should be deemed viable for each contacted RAj. (Carrel is a decision support system, so human experts ultimately make the critical decisions.)
The ProCLAIM model
ProCLAIM defines three main tasks for the MA:
• inform the proponent agents of their dialectical possible moves at each stage of deliberation, • ensure that the submitted arguments are relevant (for example, they comply with the guidelines), and
• evaluate the submitted arguments to identify the winning arguments and thus determine whether a proposed decision is valid.
To undertake these tasks, the MA references four knowledge resources (see figure 3 ). The first is an argument scheme repository. To direct the proponent agents in the submission and exchange of arguments, the MA uses a repository of argument schemes and their associated critical questions (CQs). 9 Agents construct arguments instantiating schemes and CQs that effectively encode the full argument space-that is, all possible lines of reasoning that the agent should pursue regarding a given issue.
Secondly, guideline knowledge enables the MA to check whether the arguments submitted comply with the established knowledgein particular, whether the arguments are valid instantiations of schemes in the argument scheme repository. (We can thus regard the repository as a structured abstraction of the guideline knowledge.)
Thirdly, the MA references a case-based reasoning engine to assign strengths to the submitted arguments on the basis of their associated evidence gathered from past deliberations. It also provides additional arguments deemed relevant in previous similar situations.
Finally, depending on who submitted the A g e n t s i n H e a l t h c a r e arguments, the MA can readjust the strengths of these arguments using an argument source manager, which manages the knowledge related to the agents' roles and/or reputations. It also manages knowledge related to the types of certificates or references that might empower agents to undertake some exceptional decision.
In the transplantation context, the guideline knowledge encodes medical knowledge relevant to assessing an organ's viability, and the argument scheme repository encodes the reasoning patterns used in deliberating over the organ's viability. The case-based reasoning engine evaluates the agents' submitted arguments on the basis of previous similar transplant experiences together with the arguments submitted for those experiences. Finally, the argument source manager manages the agents' reputations, using a trusted third party (the National Transplant Organization) to assess what degree of deviation from the established criteria should be allowed for each transplant unit-that is, each DA and RA.
Carrel+ makes no assumptions about the DA and RA's internal reasoning mechanisms. It lets human agents construct natural language arguments instantiating schemes 10 or lets automated agents construct arguments in a firstorder-logic programming language. 11 (This first-order argumentation has been described elsewhere, where the conflict-based interactions between arguments are also defined. 11 ) Given the constructed arguments instantiating the schemes (in whatever language) and their interactions, we apply Dung's seminal calculus of opposition 12 to determine the justified or winning arguments.
Argument-based deliberation
Once the DA i and an RA j enter the evaluation room, the deliberation process begins with the MA submitting an argument in favor of the offered organ's viability, instantiating the following viability scheme (VS):
Organ O of donor D is available And no contraindications are known for donating organ O to recipient R; Therefore, organ O is viable.
The DA i and RA j may then submit further arguments that, if accepted by the MA (that is, verified against the MA's knowledge resources to be a valid instantiation), attack or reinstate the argument for viability.
Let Sch(x 1 , ..., x n ) denote the instantiation of scheme Sch, with x 1 , ..., Suppose RA j doesn't believe s_h is a contraindication because d didn't have COPD. Then RA j might submit argument A3 = NDAS(d, copd, s_h, lung) to attack A2. A2 and A3 attack each other because the former is based on a claim that smoking history is a contraindication; the latter contradicts this claim, so it remains a moot point as to which argument should win out (see figure 4a) .
So far, we've described how the deliberating agents can address CQs by submitting arguments that instantiate schemes related to the CQs. However, the agents can also address CQs as challenges. For example, RA j can address NVS1_CQ 2 as a challenge requiring that DA i justify why s_h is a con- traindication. The challenge NVS1_CQ 2 effectively shifts the burden of proof to DA i and can thus be represented as argument A4 attacking A2. So, DA i must provide an argument A5 justifying why s_h is a contraindication. A5 will attack the challenge argument A4 and reinstate (defend) A2 (see figure 4a ). For example, A5 = GFS(d, s_h, lung) is an argument instantiating the graft failure scheme, which indicates that transplanting the lung will result in a graft failure. To capture this dual use of CQs, consider an argument scheme AS and its associated set of CQs-that is, AS_CQ 1 , ... AS_CQ n . A tuple (defend i , attack i ) represents each AS_CQ i ,where defend i and attack i are (possibly empty) sets of argument schemes. Suppose an agent has submitted the argument A1, instantiating AS. Then
• the agents can express AS_CQ i = (defend i, attack i ) as a challenge locution to A1 (that is, as an argument A2 attacking A1), in which case in order to defend A1 from A2, an agent must submit some argument A3 instantiating an argument scheme in defend i .
• the agents can express AS_CQ i as the locution of an argument A2 instantiating a scheme in attack i . A2 attacks A1 and is then subject to critical questioning in the same way as A1.
For example, NVS1_CQ 2 is represented by the tuple ({DDTS, GFS}, {NDAS, UZS}), where DDTS is the donor disease transmission scheme and UZS is the urgency zero scheme, indicating that the recipient's survival condition is so precarious that condition C can't be considered as a contraindication for this recipient. Therefore, RA j can instantiate either NDAS or UZS to attack argument A2 via NVS1_CQ 2 . On the other hand, if RA j uses NVS1_CQ2 as a challenge locution, DA i can respond to the challenge by instantiating either DDTS or GFS.
So, the argument scheme repository not only encodes the full argumentation space with respect to viability but also guides agents in exploring the full range of possible dialectical moves at each stage in an argument-based dialogue; the agents determine which schemes or CQs to instantiate to attack or defend the already submitted arguments (see figure 5 ).
Such guidance is required in safety-critical domains where it's important to ensure that deliberating agents are aware of all their dialectical obligations regarding the issue at hand. In the context of Carrel+, the agents are directed to address all issues relevant to organ viability, such as organ structure and function, delivery plans, and so forth.
Also, the MA must validate each argument that an agent submits by referencing the other knowledge sources. In particular, the guideline knowledge encodes what are deemed valid arguments instantiating schemes. For example, an argument NVS1(d, dark_hair, liver), indicating that the donor's liver is nonviable because he or she has dark hair, would obviously be an invalid instantiation of NVS1. Also, the case-based reasoning engine might indicate that although the guidelines knowledge deems an instantiation of a scheme as nonvalid, in light of the experiential knowledge acquired from recorded past case, the instantiation is a valid use of the scheme. Finally, even if the guideline knowledge or case-based reasoning engine can't validate an argument, the MA might still deem it valid if the argument source manager shows that the agent (trans- In (b) , the donor had streptococcus viridans endocarditis (sve). Argument B4 says that if d had sve, the recipient r will have a streptococcus viridans infection (svi), which is harmful. However, arguments B5 and B7 say you can prevent this infection by administrating either penicillin or teicoplanin. Argument B6 indicates that the recipient is allergic to penicillin and thus defeats B5. So, the kidney will be deemed viable only if the MA concludes that B7 defeats B4 (that is, that teicoplanin indeed prevents the recipient from getting svi).
plant unit) has a sufficiently high reputation.
While the argument scheme repository formalizes the argument-based content of each move in a dialogue, the speech acts at each stage are defined by protocols that agents must follow in the evaluation room; namely, the illocutions the agents can perform at each stage defined in this scene. As figure 6a shows, the agents enter their respective evaluation rooms in stage a 1 : DA i enters the donor evaluation room and RA j enters the recipient evaluation room. The MA coordinates the messages in these two rooms so that the proponent agents can effectively deliberate, exchanging only relevant arguments. In stage a 1 , the MA sends message 1, submitting the argument (such as A1 = VS(d, lung, r)) for viability and moving the dialogue into stage a 2 .
At this stage, the proponent agents can propose a new argument, message 2 (such as A2 = NVS1(d, s_h, lung)), which the MA might (message 3a) or might not (message 3b) accept. When the MA accepts an argument, it informs the sender (say, DA i ) of its acceptance (message 3a from stage a 3 in a 2 ) and the interlocutor (say, RA j ) of the new argument's submission (message 3a as a cycle in stage a 2 ). Also in stage a 2 , the proponent agents can query the MA for valid dialectical moves for the deliberation's given state (message 4). For example, RA j might query for schemes for attacking argument A2, and the MA would answer (message 5a) by referencing the argument scheme repository. If message 4 is ill structured, the MA might answer with message 5b.
When the proponent agents don't intend to submit more arguments, they state this in message 6, and the MA evaluates the submitted arguments to determine whether the organ is viable (message 8a) or nonviable (message 8b). However, if, after having evaluated the arguments, the MA decides that additional arguments should be submitted, it might take the dialogue from stage a 5 back to a 2 via message 3a. The MA will conclude the dialogue and inform the proponent agents of the argument evaluation (message 8a or 8b), once the timeout message (message 7) is submitted.
Argument evaluation
Once the MA has accepted the arguments as valid, it can organize them into a graph of interacting (attacking) arguments. Then it can apply Dung's calculus of opposition to determine the acceptable (winning) arguments (in particular, whether viability or nonviability is winning). This might require the MA to assign strengths to arguments or to submit further arguments.
Consider figure 3a, containing the mutually attacking arguments A2 and A3. The mutual attack results in neither argument winning. The MA resolves this impasse by assigning a preference relation to the arguments-that is, by deeming one argument as stronger than the other (and thus defeating the other). So if the MA deems A2 to be stronger than A3 (s_h remains a contraindication despite the donor not having had COPD), then the winning argument would be A2, and the MA would deem the organ nonviable. However, if the MA deems A3 stronger than A2, then A1 and A3 are the winning arguments and the organ would be viable. Alternatively, the MA might submit an additional argument that asymmetrically attacks A2, which would also make A1 the winning argument.
Similarly, in figure 3b, to decide whether to deem the kidney viable, the MA must determine whether B4 is stronger than B7 or vice versa-namely, whether teicoplanin will be effective in preventing an infection in the recipient.
Once again, the MA references its knowledge sources to assign strengths to arguments and possibly to submit additional arguments. The guideline knowledge encodes a preference relation (partial ordering) among the criteria. This lets the MA assign relative strengths to the argument schemes' instantiations and reflects that not all the acceptability criteria are of the same nature. For example, while some criteria are suggestions (such as "discard all lungs of donors with a smoking history"), others are legal obligations (for example, in Spain, HIV is an absolute contraindication for being a donor).
The MA also references guideline knowledge to construct arguments. is, it's encoded in the guideline knowledge as such), and neither DA i nor RAj refers to this condition in its deliberation, the MA may then submit the argument NVS1(d, o, cond). The MA can then readjust the arguments' relative strengths to reflect their evidential support derived from the case-based reasoning engine. Suppose the MA is evaluating two symmetrically attacking arguments, A2 and A3. If evidence gathered from previous similar experiences is sufficient to indicate that A3 wins out over A2 (for example, previous successful transplants of lungs from donors with a smoking history and no COPD), then A3 will be deemed stronger than A2. Also, through referencing the case-based reasoning engine, the MA can submit additional arguments deemed relevant in previous similar situations. (More on the case-based reasoning engine appears elsewhere. 6 )
The agents' reputations also influence the arguments' relative strengths. MA might bias its decision favoring agents with good reputations. To illustrate this with the endocarditis example (figure 3b), suppose RA j has a good record of successfully transplanting organs. Suppose also that administrating teicoplanin to prevent streptococcus viridans endocarditis (sve) from being a contraindication (RA j submits B7 = DCCAPS(teicoplanin, r, d, sve, svi)) is not a common procedure and thus isn't encoded in guideline knowledge or recorded in the case-based reasoning engine. However, because of RA j 's good reputation, MA might prefer B7 over B4 (see figure 3b ). This will enable B7's attack on B4 to succeed, making the organ viable. W e've used schemes and critical questions to map the full argumentation space with respect to organ viability for transplantation, focusing on how we can guide agents to explore all their dialectical obligations (other researchers have explored a similar idea for arguing about [and deciding] an appropriate course of action 13 ). To evaluate whether the schemes and CQs capture all the required lines of reasoning and argumentation, we're refining the argument scheme repository in collaboration with doctors from the Department of Organ and Tissue Procurement for Transplantation at the Hospital de la Santa Creu i Sant Pau. We've developed an interactive Web page (www.lsi.upc. edu/_tolchinsky/ASR) for receiving doctors' comments on the argument schemes' representation and organization of the argument scheme repository. In particular, our current concern is minimizing user overhead when interacting with the schemes (instantiating or editing them) while ensuring that these schemes still capture all the needed reasoning patterns.
We've also conducted an initial evaluation of a Cogent 14 prototype of Carrel+ on a relatively small set of examples. We developed the prototype as part of the EU Sixth Framework project Argumentation Services Platform with Integrated Components (www.
argumentation.org). ASPIC aims to develop theoretical models of argumentation-based reasoning and implement these models in software components. Owing to our initial prototype's success, we're evaluating a large-scale demonstrator of the Carrel+ system to assess these components' functionality and utility and facilitate a full-scale evaluation of our approach. 
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